261 related articles for article (PubMed ID: 25133162)
1. Hypoxia-pretreated human MSCs attenuate acute kidney injury through enhanced angiogenic and antioxidative capacities.
Zhang W; Liu L; Huo Y; Yang Y; Wang Y
Biomed Res Int; 2014; 2014():462472. PubMed ID: 25133162
[TBL] [Abstract][Full Text] [Related]
2. 3D spheroid culture enhances survival and therapeutic capacities of MSCs injected into ischemic kidney.
Xu Y; Shi T; Xu A; Zhang L
J Cell Mol Med; 2016 Jul; 20(7):1203-13. PubMed ID: 26914637
[TBL] [Abstract][Full Text] [Related]
3. Adipose-Derived Mesenchymal Stromal Cells Under Hypoxia: Changes in Extracellular Vesicles Secretion and Improvement of Renal Recovery after Ischemic Injury.
Collino F; Lopes JA; Corrêa S; Abdelhay E; Takiya CM; Wendt CHC; de Miranda KR; Vieyra A; Lindoso RS
Cell Physiol Biochem; 2019; 52(6):1463-1483. PubMed ID: 31099507
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats.
Zhuo W; Liao L; Fu Y; Xu T; Wu W; Yang S; Tan J
Transplant Proc; 2013 Mar; 45(2):503-10. PubMed ID: 23498785
[TBL] [Abstract][Full Text] [Related]
5. The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury.
Gao J; Liu R; Wu J; Liu Z; Li J; Zhou J; Hao T; Wang Y; Du Z; Duan C; Wang C
Biomaterials; 2012 May; 33(14):3673-81. PubMed ID: 22361096
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
Carmona M; Paco-Meza LM; Ortega R; Cañadillas S; Caballero-Villarraso J; Blanco A; Herrera C
Pathol Res Pract; 2022 Feb; 230():153756. PubMed ID: 35032832
[TBL] [Abstract][Full Text] [Related]
7. Use of mesenchymal stem cells and darbepoetin improve ischemia-induced acute kidney injury outcomes.
Altun B; Yilmaz R; Aki T; Akoglu H; Zeybek D; Piskinpasa S; Uckan D; Purali N; Korkusuz P; Turgan C
Am J Nephrol; 2012; 35(6):531-9. PubMed ID: 22653289
[TBL] [Abstract][Full Text] [Related]
8. Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury.
Zilberman-Itskovich S; Abu-Hamad R; Zarura R; Sova M; Hachmo Y; Stark M; Neuman S; Slavin S; Efrati S
PLoS One; 2019; 14(9):e0222354. PubMed ID: 31513644
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury.
Selim RE; Ahmed HH; Abd-Allah SH; Sabry GM; Hassan RE; Khalil WKB; Abouhashem NS
Appl Biochem Biotechnol; 2019 Sep; 189(1):284-304. PubMed ID: 30976980
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury.
Xing L; Cui R; Peng L; Ma J; Chen X; Xie RJ; Li B
Stem Cell Res Ther; 2014 Aug; 5(4):101. PubMed ID: 25145540
[TBL] [Abstract][Full Text] [Related]
11. Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment.
Masoud MS; Anwar SS; Afzal MZ; Mehmood A; Khan SN; Riazuddin S
J Transl Med; 2012 Dec; 10():243. PubMed ID: 23217165
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.
Tseng WC; Lee PY; Tsai MT; Chang FP; Chen NJ; Chien CT; Hung SC; Tarng DC
Stem Cell Res Ther; 2021 Jun; 12(1):367. PubMed ID: 34183058
[TBL] [Abstract][Full Text] [Related]
13. Stem Cell Therapy Ameliorates Ischemia-reperfusion Induced Kidney Injury After 24 Hours Reperfusion.
Hafazeh L; Changizi-Ashtiyani S; Ghasemi F; Najafi H; Babaei S; Haghverdi F
Iran J Kidney Dis; 2019 Nov; 13(6):380-388. PubMed ID: 31880584
[TBL] [Abstract][Full Text] [Related]
14. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
[TBL] [Abstract][Full Text] [Related]
15. Adipose-derived mesenchymal stem cells therapy for acute kidney injury induced by ischemia-reperfusion in a rat model.
Zhang JB; Wang XQ; Lu GL; Huang HS; Xu SY
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1232-1240. PubMed ID: 28688148
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.
Qi S; Wu D
Int J Mol Med; 2013 Dec; 32(6):1262-72. PubMed ID: 24126885
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury.
Chen YT; Yang CC; Zhen YY; Wallace CG; Yang JL; Sun CK; Tsai TH; Sheu JJ; Chua S; Chang CL; Cho CL; Leu S; Yip HK
Stem Cell Res Ther; 2013 May; 4(3):62. PubMed ID: 23726287
[TBL] [Abstract][Full Text] [Related]
18. Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1.
Zou X; Zhang G; Cheng Z; Yin D; Du T; Ju G; Miao S; Liu G; Lu M; Zhu Y
Stem Cell Res Ther; 2014 Mar; 5(2):40. PubMed ID: 24646750
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats.
Ashour RH; Saad MA; Sobh MA; Al-Husseiny F; Abouelkheir M; Awad A; Elghannam D; Abdel-Ghaffar H; Sobh M
Stem Cell Res Ther; 2016 Sep; 7(1):126. PubMed ID: 27585525
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid pretreatment of mesenchymal stem cells enhances the therapeutic effect on acute kidney injury.
Zhang Y; Wang X; Ji Y; Hong H; Geng X; Zhang K; Fu Z; Cai G; Chen X; Li P; Hong Q
Cell Commun Signal; 2024 May; 22(1):291. PubMed ID: 38802835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
